159 related articles for article (PubMed ID: 19216216)
1. Expression of leucine-rich repeats and immunoglobulin-like domains (LRIG) proteins in human ependymoma relates to tumor location, WHO grade, and patient age.
Yi W; Haapasalo H; Holmlund C; Järvelä S; Raheem O; Bergenheim AT; Hedman H; Henriksson R
Clin Neuropathol; 2009; 28(1):21-7. PubMed ID: 19216216
[TBL] [Abstract][Full Text] [Related]
2. Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors.
Guo D; Nilsson J; Haapasalo H; Raheem O; Bergenheim T; Hedman H; Henriksson R
Acta Neuropathol; 2006 Mar; 111(3):238-46. PubMed ID: 16532360
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of LRIG proteins in meningiomas: correlation between estrogen receptor status and LRIG expression.
Ghasimi S; Haapasalo H; Eray M; Korhonen K; Brännström T; Hedman H; Andersson U
J Neurooncol; 2012 Jul; 108(3):435-41. PubMed ID: 22484910
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic LRIG2 expression is associated with poor oligodendroglioma patient survival.
Holmlund C; Haapasalo H; Yi W; Raheem O; Brännström T; Bragge H; Henriksson R; Hedman H
Neuropathology; 2009 Jun; 29(3):242-7. PubMed ID: 18992012
[TBL] [Abstract][Full Text] [Related]
5. LMO7 and LIMCH1 interact with LRIG proteins in lung cancer, with prognostic implications for early-stage disease.
Karlsson T; Kvarnbrink S; Holmlund C; Botling J; Micke P; Henriksson R; Johansson M; Hedman H
Lung Cancer; 2018 Nov; 125():174-184. PubMed ID: 30429017
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) in HP75 pituitary adenoma cell line.
Guo D; Han L; Shu K; Chen J; Lei T
J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):91-4. PubMed ID: 17393120
[TBL] [Abstract][Full Text] [Related]
7. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.
Singh PK; Gutmann DH; Fuller CE; Newsham IF; Perry A
Mod Pathol; 2002 May; 15(5):526-31. PubMed ID: 12011257
[TBL] [Abstract][Full Text] [Related]
8. Peroxiredoxins and their expression in ependymomas.
Haapasalo T; Nordfors K; Järvelä S; Kok E; Sallinen P; Kinnula VL; Haapasalo HK; Soini Y
J Clin Pathol; 2013 Jan; 66(1):12-7. PubMed ID: 23076395
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor overexpression is common and not correlated to gene copy number in ependymoma.
Friedrich C; von Bueren AO; Kolevatova L; Bernreuther C; Grob T; Sepulveda-Falla D; van den Boom L; Westphal M; Simon R; Glatzel M
Childs Nerv Syst; 2016 Feb; 32(2):281-90. PubMed ID: 26686534
[TBL] [Abstract][Full Text] [Related]
10. LRIG and cancer prognosis.
Lindquist D; Kvarnbrink S; Henriksson R; Hedman H
Acta Oncol; 2014 Sep; 53(9):1135-42. PubMed ID: 25180912
[TBL] [Abstract][Full Text] [Related]
11. Expression of LRIG1 and LRIG3 correlates with human papillomavirus status and patient survival in cervical adenocarcinoma.
Muller S; Lindquist D; Kanter L; Flores-Staino C; Henriksson R; Hedman H; Andersson S
Int J Oncol; 2013 Jan; 42(1):247-52. PubMed ID: 23165628
[TBL] [Abstract][Full Text] [Related]
12. In vivo analysis of Lrig genes reveals redundant and independent functions in the inner ear.
Del Rio T; Nishitani AM; Yu WM; Goodrich LV
PLoS Genet; 2013; 9(9):e1003824. PubMed ID: 24086156
[TBL] [Abstract][Full Text] [Related]
13. Redistribution of LRIG proteins in psoriasis.
Karlsson T; Mark EB; Henriksson R; Hedman H
J Invest Dermatol; 2008 May; 128(5):1192-5. PubMed ID: 18037903
[TBL] [Abstract][Full Text] [Related]
14. Nucleolin overexpression is associated with an unfavorable outcome for ependymoma: a multifactorial analysis of 176 patients.
Chen C; Chen L; Yao Y; Qin Z; Chen H
J Neurooncol; 2016 Mar; 127(1):43-52. PubMed ID: 26615563
[TBL] [Abstract][Full Text] [Related]
15. Study of stem cell marker nestin and its correlation with vascular endothelial growth factor and microvascular density in ependymomas.
Nambirajan A; Sharma MC; Gupta RK; Suri V; Singh M; Sarkar C
Neuropathol Appl Neurobiol; 2014 Oct; 40(6):714-25. PubMed ID: 24224478
[TBL] [Abstract][Full Text] [Related]
16. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.
Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL
Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600
[TBL] [Abstract][Full Text] [Related]
17. Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signaling.
Figarella-Branger D; Lechapt-Zalcman E; Tabouret E; Jünger S; de Paula AM; Bouvier C; Colin C; Jouvet A; Forest F; Andreiuolo F; Quintin-Roue I; Machet MC; Heitzmann A; Milin S; Sevestre H; Godfraind C; Labrousse F; Metellus P; Scavarda D; Pietsch T
Neuro Oncol; 2016 Jul; 18(7):919-27. PubMed ID: 26984744
[TBL] [Abstract][Full Text] [Related]
18. Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age.
Korshunov A; Neben K; Wrobel G; Tews B; Benner A; Hahn M; Golanov A; Lichter P
Am J Pathol; 2003 Nov; 163(5):1721-7. PubMed ID: 14578171
[TBL] [Abstract][Full Text] [Related]
19. LRIGs: A Prognostically Significant Family with Emerging Therapeutic Competence against Cancers.
Malik U; Javed A
Curr Cancer Drug Targets; 2017; 17(1):3-16. PubMed ID: 27628597
[TBL] [Abstract][Full Text] [Related]
20. Region Specific Differences of Claudin-5 Expression in Pediatric Intracranial Ependymomas: Potential Prognostic Role in Supratentorial Cases.
Virág J; Haberler C; Baksa G; Piurkó V; Hegedüs Z; Reiniger L; Bálint K; Chocholous M; Kiss A; Lotz G; Glasz T; Schaff Z; Garami M; Hegedűs B
Pathol Oncol Res; 2017 Apr; 23(2):245-252. PubMed ID: 27395057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
